Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB218965

CRACC/SLAMF7 Antibody (MM0200-6G17), Biotin, Novus Biologicals™
SDP

Catalog No. NB218965 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB218965 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB218965 Supplier Novus Biologicals Supplier No. NBP212206B
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

CRACC/SLAMF7 Monoclonal antibody specifically detects CRACC/SLAMF7 in Human samples. It is validated for Flow Cytometry

Specifications

Antigen CRACC/SLAMF7
Applications Flow Cytometry
Classification Monoclonal
Clone MM0200-6G17
Conjugate Biotin
Formulation PBS
Gene Alias 19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7
Host Species Mouse
Immunogen Human recombinant CRACC/SLAMF7
Purification Method Protein G purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Gene ID (Entrez) 57823
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.